Authors:
Arens, R
Tesselaar, K
Baars, PA
van Schijndel, GMW
Hendriks, J
Pals, ST
Krimpenfort, P
Borst, J
van Oers, MHJ
van Lier, RAW
Citation: R. Arens et al., Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFN gamma-mediated B cell depletion, IMMUNITY, 15(5), 2001, pp. 801-812
Authors:
Vellenga, E
van Agthoven, M
Croockewit, AJ
Verdonck, LF
Wijermans, PJ
van Oers, MHJ
Volkers, CP
van Imhoff, GW
Kingma, T
Uyl-de Groot, CA
Fibbe, WE
Citation: E. Vellenga et al., Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study, BR J HAEM, 114(2), 2001, pp. 319-326
Authors:
van Baarle, D
Hovenkamp, E
Callan, MFC
Wolthers, KC
Kostense, S
Tan, LC
Niesters, HGM
Osterhaus, ADME
McMichael, AJ
van Oers, MHJ
Miedema, F
Citation: D. Van Baarle et al., Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-relatednon-Hodgkin lymphoma, BLOOD, 98(1), 2001, pp. 146-155
Authors:
Nurmohamed, MT
Soesan, M
van Oers, MHJ
Dijkmans, BAC
van Soesbergen, RM
Citation: Mt. Nurmohamed et al., Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis, RHEUMATOLOG, 39(12), 2000, pp. 1431-1433
Authors:
Lokhorst, HM
Schattenberg, A
Cornelissen, JJ
van Oers, MHJ
Fibbe, W
Russell, I
Van der Donk, NWCJ
Verdonck, LF
Citation: Hm. Lokhorst et al., Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome, J CL ONCOL, 18(16), 2000, pp. 3031-3037
Authors:
van Baarle, D
Hovenkamp, E
Dukers, NHTM
Renwick, N
Kersten, MJ
Goudsmit, J
Coutinho, RA
Miedema, F
van Oers, MHJ
Citation: D. Van Baarle et al., High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission, J INFEC DIS, 181(6), 2000, pp. 2045-2049
Authors:
Lokhorst, HM
Sonneveld, P
Cornelissen, JJ
Joosten, P
Kooy, MV
Meinema, J
Nieuwenhuis, HK
van Oers, MHJ
Richel, DJ
Segeren, CN
Veth, G
Verdonck, LF
Wijermans, PW
Citation: Hm. Lokhorst et al., Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma, BONE MAR TR, 23(4), 1999, pp. 317-322
Authors:
Segeren, CM
Sonneveld, P
van der Holt, B
Baars, JW
Biesma, DH
Cornellissen, JJ
Croockewit, AJ
Dekker, AW
Fibbe, WE
Lowenberg, B
Kooy, MV
van Oers, MHJ
Richel, DJ
Schouten, HC
Vellenga, E
Verhoef, GEG
Wijermans, PW
Wittebol, S
Lokhorst, HM
Citation: Cm. Segeren et al., Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma, BR J HAEM, 105(1), 1999, pp. 127-130
Authors:
van Baarle, D
Hovenkamp, E
Kersten, MJ
Klein, MR
Miedema, F
van Oers, MHJ
Citation: D. Van Baarle et al., Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: No association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma, BLOOD, 93(11), 1999, pp. 3949-3955